BioMaxima S.A.
BMX.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| - Cash | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| + Debt | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Enterprise Value | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| Revenue | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Growth | 13% | -67.5% | 81.9% | – |
| Gross Profit | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Margin | 44% | 42.8% | 37.7% | 36.7% |
| EBITDA | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Margin | 8.8% | 7% | 26.7% | 18.7% |
| Net Income | PLN 0 | PLN 0 | PLN 0 | PLN 0 |
| % Margin | 1% | 1.3% | 20.1% | 13% |
| EPS Diluted | 0.13 | 0.14 | 6.48 | 2.29 |
| % Growth | -7.1% | -97.8% | 183% | – |
| Operating Cash Flow | -PLN 0 | PLN 0 | PLN 0 | -PLN 0 |
| Capital Expenditures | -PLN 0 | -PLN 0 | -PLN 0 | -PLN 0 |
| Free Cash Flow | -PLN 0 | -PLN 0 | PLN 0 | -PLN 0 |